MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 31 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,476,000 | -6.1% | 193,228 | +2.5% | 0.07% | -14.6% |
| Q3 2015 | $1,572,000 | -26.9% | 188,522 | +1.6% | 0.08% | -20.4% |
| Q2 2015 | $2,151,000 | -36.2% | 185,462 | -52.1% | 0.10% | -39.1% |
| Q1 2015 | $3,372,000 | +17.3% | 387,134 | +42.3% | 0.17% | +10.5% |
| Q4 2014 | $2,875,000 | +182.1% | 272,013 | +72.7% | 0.15% | +150.8% |
| Q3 2014 | $1,019,000 | – | 157,540 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 5,016,164 | $10,835,000 | 2.15% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,836,000 | 1.91% |
| Asymmetry Capital Management, L.P. | 354,853 | $766,000 | 1.37% |
| Lion Point Capital, LP | 6,374,740 | $13,769,000 | 1.28% |
| Granite Point Capital Management, L.P. | 2,700,000 | $5,832,000 | 0.91% |
| VHCP Management II, LLC | 1,486,676 | $3,211,000 | 0.85% |
| Boxer Capital, LLC | 4,800,000 | $10,368,000 | 0.59% |
| Avoro Capital Advisors LLC | 6,200,000 | $13,392,000 | 0.39% |
| 683 Capital Management, LLC | 925,382 | $1,999,000 | 0.23% |
| Islet Management, LP | 875,000 | $1,890,000 | 0.18% |